DISSEMINATED INFECTION WITH VANCOMYCIN-INTERMEDIATE STAPHYLOCOCCUS AUREUS (VISA) IN A 37-YEAR-OLD

被引：0
|
作者：
Heller, David [1 ]
Sisson, Stephen [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S471 / S472
页数：2
相关论文
共 50 条
  • [31] Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
    Rose, Warren E.
    Leonard, Steven N.
    Rossi, Kerri L.
    Kaatz, Glenn W.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 805 - 807
  • [32] Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
    Chih-Cheng Lai
    Chi-Chung Chen
    Yin-Ching Chuang
    Hung-Jen Tang
    Scientific Reports, 7
  • [33] Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
    Zhanel, George G.
    Voth, Dylan
    Nichol, Kim
    Karlowsky, James A.
    Noreddin, Ayman M.
    Hoban, Daryl J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 364 - 369
  • [34] A Mutation of RNA Polymerase β′ Subunit (RpoC) Converts Heterogeneously Vancomycin-Intermediate Staphylococcus aureus (hVISA) into "Slow VISA"
    Matsuo, Miki
    Hishinuma, Tomomi
    Katayama, Yuki
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4215 - 4225
  • [35] Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection
    Burnham, Jason P.
    Burnham, Carey-Ann D.
    Warren, David K.
    Kollef, Marin H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5546 - 5553
  • [36] Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
    Zhang, Shanshan
    Sun, Xiaoxi
    Chang, Wenjiao
    Dai, Yuanyuan
    Ma, Xiaoling
    PLOS ONE, 2015, 10 (08):
  • [37] Emergence of vancomycin-intermediate resistant Staphylococcus aureus in north of Palestine
    Adwan, Ghaleb
    Abu-Shanab, Bassam
    Odeh, Marwan
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2009, 2 (05) : 44 - 48
  • [38] Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus
    Hageman, Jeffrey C.
    Patel, Jean
    Franklin, Patrick
    Miscavish, Karen
    McDougal, Linda
    Lonsway, David
    Khan, Fazle N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (04) : 440 - 442
  • [39] Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
    de Oliveira Silveira, Alessandro Conrado
    da Cunha, Gabriela Rosa
    Caierao, Juliana
    Mendes de Cordova, Caio Mauricio
    d'Azevedo, Pedro Alves
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (05): : 466 - 472
  • [40] Survivability and fitness cost of heterogeneous vancomycin-intermediate Staphylococcus aureus
    Singh, Avinash
    Singh, Sanjay
    Singh, Jyoti
    Rahman, Mohibur
    Pathak, Ashutosh
    Prasad, Kashi Nath
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 35 (03) : 415 - 416
12345